Corgi Data & Surveillance ETF
Corgi Data & Surveillance ETF (EYES) Expected Move
EYES expected move through Oct 16, 2026 is 10.3%, with 21 days to expiration. The implied range is $26.32 to $32.34, based on the previous trading day's options prices.
Read more
Tracking the EYES expected move helps you see how far Corgi Data & Surveillance ETF's options market is pricing the stock to travel over a given period — whether that's the next day, week, or earnings cycle. Corgi Data & Surveillance ETF's expected move is derived directly from option premiums and gives you an objective range to plan trades, set strikes, and manage risk. Use our scanner to monitor the EYES expected move for this week's options, in real time.
The expected move is typically calculated from at-the-money straddle prices (or a blend of straddles and strangles) and represents roughly a one-standard-deviation range over the chosen timeframe. For EYES, comparing the implied expected move to actual realized moves over similar windows tells you whether the options market has historically overestimated or underestimated volatility. The EYES expected move for this week's options pricing is especially useful for short-dated traders, earnings players, and anyone selling premium who needs to know where the market thinks Corgi Data & Surveillance ETF is unlikely to go.
On August 30, 2022, Second Sight Medical Products, Inc. underwent a reverse merger, resulting in its acquisition by Nano Precision Medical, Inc. Previously, Second Sight specialized in the creation, production, and commercialization of implantable visual prosthetics, with the goal of restoring artificial vision to individuals who are blind. The company's overarching objective was to advance technologies designed to aid the sight-impaired community. A notable offering was the Orion Visual Cortical Prosthesis System, an implanted cortical stimulator developed to deliver functional artificial vision.
This system targeted individuals suffering from blindness caused by a range of conditions, such as glaucoma, diabetic retinopathy, damage or disease affecting the optic nerve, and other forms of eye injury. Established in 1998, the company was based in Sylmar, California.
Iron condors, weekly premium sales, directional swing trades — they all live or die by where the market thinks the stock won't go. Our scanner tracks the EYES expected move across every expiration, benchmarks it against realized moves, and shows you when implied ranges are out of line with history. The Corgi Data & Surveillance ETF expected move for this week's options is the fastest read on short-term risk, which gives you a quick way to interpret what the options market thinks about EYES.
EYES Price
Drag chart to pan. Drag axes to zoom.
| Expiration | DTE | Expected move (USD) | Expected move (%) | Upper price | Lower price |
|---|---|---|---|---|---|
| Oct 16, 2026 | 21 | $3.01 | 10.3% | $32.34 | $26.32 |
| Nov 20, 2026 | 56 | $3.56 | 12.1% | $32.89 | $25.77 |
| Dec 18, 2026 | 84 | $4.49 | 15.3% | $33.82 | $24.84 |
| Mar 19, 2027 | 175 | $6.35 | 21.7% | $35.68 | $22.98 |
As of September 24, 2026
Know What the Market Expects From EYES
Track the EYES expected move across every expiration, filter by IV rank and liquidity, and trade around the range the market is already pricing in.
Start your 14-day free trial→